Clinical Trial: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of UBT251 Injection in Participants with Moderate to Severe Obstructive Sleep Apnea (OSA) and Obesity Who Are Not Treated with Positive Airway Pressure (UNISHAPE-OSA-1) (China)

China, Oct. 27 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of UBT251 Injection in Participants with Moderate to Severe Obstructive Sleep Apnea (OSA) and Obesity Who Are Not Treated with Positive Airway Pressure (UNISHAPE-OSA-1)'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600135162

Registration Time: 2026/10/26

Type: Interventional study

Primary Sponsor: Peking University People's Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=348426

Published by HT Digital Content Services with p...